CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-12-11 | AZAB MOHAMMAD Director | Exercise or conversion · Stock Option (Right to Buy) | +2,469 | 0 | ||
| 2015-11-24 | HOLLER FRANK A Director | Exercise or conversion | +2,057 | $5.22 | $11K | 176,864 |
| 2015-11-24 | HOLLER FRANK A Director | Shares withheld for taxes | −995 | $9.39 | $9K | 175,869 |
| 2015-11-24 | HOLLER FRANK A Director | Exercise or conversion · Stock Option (Right to Buy) | −2,057 | 0 | ||
| 2015-11-04 | PATOU GARY Director | Exercise or conversion | +3,497 | $5.22 | $18K | 6,041 |
| 2015-11-04 | PATOU GARY Director | Shares withheld for taxes | −1,955 | $8.32 | $16K | 4,086 |
| 2015-11-04 | PATOU GARY Director | Exercise or conversion · Stock Option (Right to Buy) | −3,497 | 0 | ||
| 2015-11-02 | TARNOW MICHAEL M Director | Exercise or conversion | +5,041 | $5.22 | $26K | 60,208 |
| 2015-11-02 | TARNOW MICHAEL M Director | Gift | −5,041 | 55,167 | ||
| 2015-11-02 | TARNOW MICHAEL M Director | Exercise or conversion · Stock Option (Right to Buy) | −5,041 | 0 | ||
| 2015-09-24 | GOLDBERG Y. PAUL VP of Clinical Development | Sale | −12,000 | $8.60 | $103K | 6,000 |
| 2015-09-23 | GOLDBERG Y. PAUL VP of Clinical Development | Sale | −4,000 | $9.02 | $36K | 18,000 |
| 2015-09-22 | GOLDBERG Y. PAUL VP of Clinical Development | Exercise or conversion | +411 | $5.22 | $2K | 6,514 |
| 2015-09-22 | GOLDBERG Y. PAUL VP of Clinical Development | Shares withheld for taxes | −198 | $9.53 | $2K | 6,316 |
| 2015-09-22 | GOLDBERG Y. PAUL VP of Clinical Development | Exercise or conversion | +2,057 | $3.21 | $7K | 8,373 |
| 2015-09-22 | GOLDBERG Y. PAUL VP of Clinical Development | Shares withheld for taxes | −610 | $9.53 | $6K | 7,763 |
| 2015-09-22 | GOLDBERG Y. PAUL VP of Clinical Development | Exercise or conversion | +1,028 | $3.77 | $4K | 8,791 |
| 2015-09-22 | GOLDBERG Y. PAUL VP of Clinical Development | Shares withheld for taxes | −305 | $9.53 | $3K | 8,486 |
| 2015-09-22 | GOLDBERG Y. PAUL VP of Clinical Development | Exercise or conversion | +5,144 | $3.07 | $16K | 13,630 |
| 2015-09-22 | GOLDBERG Y. PAUL VP of Clinical Development | Shares withheld for taxes | −1,525 | $9.53 | $15K | 12,105 |
Page 36 of 42 · 836 trades